Riham F George

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Molecular Docking

Tyrosine Kinase

Neuropathic Pain

Anti Inflammatory

Top Venues

Future medicinal chemistry

Archiv der Pharmazie

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Zeinab S Abd-Rabo, Aya M Serry, Riham F George
An overview of pyridazin-3(2 H )-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer. Future medicinal chemistry 16 (16) (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry (2024)
Zeinab S Abd-Rabo, Aya M Serry, Riham F George
An overview of pyridazin-3(2 H )-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer. Future medicinal chemistry (2024)
Mona F Said, Riham F George, Walid Fayed, Ahmed A F Soliman, Rana H Refaey
Investigations of new N 1 -substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity. Future medicinal chemistry 16 (4) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry (2024)
Abdalla R Mohamed, Ahmed Mostafa, Mahmoud A El Hassab, Gomaa M Hedeab, Sara H Mahmoud, Riham F George, Hanan H Georgey, Nagwa M Abdel Gawad, Mohamed Kandeel El-Ashrey
Insights into targeting SARS-CoV-2: design, synthesis, in silico studies and antiviral evaluation of new dimethylxanthine derivatives. RSC medicinal chemistry 14 (5) (2023)
Nada A A M Aziz, Riham F George, Khaled El-Adl, Walaa R Mahmoud
Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFR T790M tyrosine kinase inhibitors. RSC advances 12 (20) (2022)
Nada A A M Aziz, Riham F George, Khaled El-Adl, Walaa R Mahmoud
Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Archiv der Pharmazie (2022)
Mona F Said, Riham F George, Andrea Petreni, Claudiu T Supuran, Nada M Mohamed
Synthesis, molecular modelling and QSAR study of new N- phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors with antiproliferative activity. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Kamilia M Amin, Gehan H Hegazy, Riham F George, Nahla R Ibrahim, Nada M Mohamed
Design, synthesis, and pharmacological characterization of some 2-substituted-3-phenyl-quinazolin-4(3H)-one derivatives as phosphodiesterase inhibitors. Archiv der Pharmazie 354 (9) (2021)
Rehab H Abd El-Aleam, Riham F George, Hanan H Georgey, Hamdy M Abdel-Rahman
Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance. RSC advances 11 (58) (2021)
Nermin Samir, Riham F George, Eman Z Elrazaz, Iriny M Ayoub, ElSayed M Shalaby, Jasper Rikkert Plaisier, Nicola Demitri, Michael Wink
Synthesis of some tropane-based compounds targeting colon cancer. Future medicinal chemistry 12 (23) (2020)
Siva S Panda, Adel S Girgis, Hitesh H Honkanadavar, Riham F George, Aladdin M Srour
Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future medicinal chemistry 12 (15) (2020)
Rehab H Abd El-Aleam, Riham F George, Kevin J Lee, Adam B Keeton, Gary A Piazza, Amr A Kamel, Mahmoud E El-Daly, Ghaneya S Hassan, Hamdy M Abdel-Rahman
Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity. Archiv der Pharmazie 352 (8) (2019)
Israa A Seliem, Siva S Panda, Adel S Girgis, Yosra I Nagy, Riham F George, Walid Fayad, Nehmedo G Fawzy, Tarek S Ibrahim, Amany M M Al-Mahmoudy, Rajeev Sakhuja, Zakaria K M Abdel-Samii
Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids. Chemical biology & drug design 95 (2) (2019)